*Note: For the investigational use of Adipose Derived Stem Cells (ADSC’s) for clinical research and deployment.
Systemic Lupus Erythematosus, considered a collection of diseases, is an autoimmune disorder in which the immune system attacks healthy tissues, especially in the joints (especially fingers, wrists, hands, and knees). Patients often develop fatigue, rash, and swollen lymph nodes, but many body parts can be affected. As with other autoimmune conditions, anti-inflammatory medications and immune-suppressants are used commonly for treatment. Sometimes cytotoxic drugs are used for severe cases. This debilitating disease is painful and unbearable. Some patients with lupus have suicidal thoughts due to its life-threatening symptoms. FDA-approved drugs to control lupus symptoms for the past 40 years have been antimalarial drugs, azathioprine, cyclophosphamide and prednisone.
Stem Cells And Lupus
A successful treatment for lupus should balance the disease as the symptoms flare and subside. However, until recently this balance was not met with traditional treatment and therapies. We have found that with a patient’s own adult stem cells, there is new hope for the intractable autoimmune disease. It has been confirmed that intravenous administration of adult stem cells can restores normal bodily function to tissue and organs affected by lupus, also reducing or eliminating the need for steroid and immunosuppressant medications.
Stem cells from adults are undifferentiated, meaning they can change into the cells of many organs and tissues in the body. Useful in countless therapies, they repair damaged fibers and revitalize failing cells through cell division, a process in which they multiply indefinitely. The science of stem cell therapy has improved greatly over recent years with much progress being made in new treatment possibilities.
The Center for Regenerative Cell Medicine has developed a specific SVF deployment protocol that attempts to utilize the immuno-regulatory and anti-inflammatory properties of SVF (rich in mesenchymal stem cells and growth factors) to mitigate the effects of Lupus. SVF is deployed systemically and may require repeat dosing. This is done as an outpatient at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately three hours.